Welcome to CARBOGEN AMCIS, a member of the Dishman Carbogen Amcis Group. We provide drug development and commercialisation services to the pharmaceutical and biopharmaceutical industries, at all stages of drug development. Our capabilities span from contract chemical process research and development to the supply of Active Pharmaceutical Ingredients (APIs) - as well as drug products for preclinical studies, clinical trials and commercial use. Besides being a service provider we also offer high quality Cholesterol and Vitamin D analog products produced at our facility in The Netherlands. These products are used in a variety of markets around the globe.
Our focus is to help customers create a better world by becoming the partner of choice for development and manufacture. The guiding principles for our service are our passion for great science supported by timely communication and backed by our total commitment to YOUR project.
We forge close collaboration and open communication with our customers which ensures we work effectively as a team, meeting (if not exceeding) our customers' expectations. We aim to manufacture pharmaceutical ingredients at the highest standard of GMP whilst protecting the environment.
We are a partner you can trust and we look forward to helping you move your project faster to the market!
We bring science to life by providing innovative solutions in products and services, contributing to the well-being of people and the planet.
We apply our experience and outstanding quality in the provision of exceptional chemical process development, manufacturing & formulation services and products for our customers . We focus on high efficiency , reliability and finding innovative, safe, economically and environmentally optimal solutions.
With over 30 years’ experience, we have supported the pharmaceutical and biopharmaceutical industries with drug development and bringing new drugs to market to improve human health.
CARBOGEN AMCIS was born out of CarboGen, founded in 1990 at the University of Zurich and also AMCIS which was founded in 1982. The companies were both acquired by Solutia in 2000 and merged into the single legal entity now known as CARBOGEN AMCIS AG. Since then, we have continued to grow organically, and employ more than 600 people.
In August 2006, CARBOGEN AMCIS AG was acquired by Dishman Carbogen Amcis Ltd. (previously known as Dishman Pharmaceuticals and Chemicals Limited,) – allowing us within the Dishman Carbogen Amcis group to provide our customers with a fully flexible and effective customised delivery strategy for the entire life of a compound. This partnership has enabled CARBOGEN AMCIS to maintain its position as an industry leader and outsourcing partner for complex highly potent APIs and ADCs.
Development and cGMPmanufacturing of Highly Potent API including Antibody Drug Conjugates (ADC)
Our facility located in Bubendorf – a municipality in the district of Liestal in the canton of Basel-Country in Switzerland – is the current headquarters of CARBOGEN AMCIS.
The larger scale production facility was opened in 1987, and in more than 25-year of history it has continuously adapted to the changing needs of the pharmaceutical industry.
Activities
+41 58 909 00 00
+41 58 909 00 52
info@carbogen-amcis.com
By public transport
By plane
By car
Development and medium scale cGMP manufacturing including chromatography
Located in the heart of Switzerland, our facility in Aarau is centrally located between Zurich, Basel and Lucerne. The facility opened in 1994 after 4 years of operation at the University of Zurich. We aim to provide a wide range of technology tools such as solid state analysis, chromatography separation, isolation and analytical capabilities.
Activities
CARBOGEN AMCIS AG
Schachenallee 29
CH-5001 Aarau
Switzerland
+41 58 909 00 01
+41 58 909 00 50
info@carbogen-amcis.com
By public transport
By plane
By car
Development and medium scale manufacturing
Our facility in Hunzenschwil (Neuland) – in the district of Lenzburg in the canton of Aargau in Switzerland – is located 25 km West of Zurich. The facility was opened in 2000 and is our second site to house laboratories for development activities with highly potent compounds. The site will be expanded with a new API plant. Construction works will begin in 2021. The new facility will fully operate by summer 2024.
Activities
CARBOGEN AMCIS AG
Neulandweg 5
CH-5502 Hunzenschwil
Switzerland
+41 58 909 00 02
+41 58 909 00 54
info@carbogen-amcis.com
By public transport
By plane
By Car
Development HiPo and small scale production including chromatography and lyophilisation
Our facility in Vionnaz which opened in 2015 is located 70 km east of Geneva and is fully cGMP compliant. The site features a process development laboratory, a dedicated QC laboratory and 2 production units fitted with reactors up to 30 L, chromatography and a freeze dryer for lyophilisation.
Activities
+41 58 909 00 03
info@carbogen-amcis.com
By public transport
By plane
By car
Development and manufacturing and non-GMP
Our facility in Manchester is fully integrated into the in-house supply chain for complex APIs.
Activities
+44 161 223 3344
+41 58 909 00 52
info@carbogen-amcis.com
By public transport
By car
By plane
Drug product - Early phase
Our 10,000 square meter facility in Riom opened in 1998. Our site focuses on formulation, aseptic filling, cytotoxics as well as other highly potent drugs and biologics. A new facility approximately 7 km away from the existing site will be added in Saint-Beauzire. Operations at the new site are slated to start by April 2023.
Activities
+33 4 73 33 72 40
info@carbogen-amcis.com
By car
By train
By plane
Custom development and automated aseptic production of liquid and lyophilized drug product
Our new state-of-the-art facility, opened in Q1 2023, is dedicated to the development, sterile production, testing and release of injectable drug products. This facility has two fully automated filling lines and will allow CARBOGEN AMCIS to supply customers with clinical batches for phase III clinical trials and small-scale for commercial. The facility has the capability to handle complex formulations, including a large range of APIs from biologics to highly potent compounds.
Activities
CARBOGEN AMCIS SAS
4 Rue Blaise Pascal
63360 Saint-Beauzire
France
+33 4 73 33 72 40
info@carbogen-amcis.com
By car
By train
By plane
Large scale manufacturing
Shanghai, the largest economic and trade center in China, contains our fully self-supporting GMP compliant development and production site. Our facility is located in the Shanghai Chemical Industry Park (SCIP) and is designed for large scale manufacturing of raw materials, intermediates and API.
The site is equipped with 13 reactors, segregated into 4 separate suites and has reactor capacities from 500 L to 8000 L. With an international team of highly qualified specialists, our facility can provide efficient and scalable solutions to customers globally.
Activities
CARBOGEN AMCIS (Shanghai) Co., Ltd.
+86 21 6712 1166
+86 21 6712 0811
info@carbogen-amcis.com
By public transport
Train
Bus
By car / taxi
By plane
Large scale manufacturing of Cholesterol and Vitamin D analogs
CARBOGEN AMCIS B.V. is active in the manufacturing, marketing/sales and distribution of Vitamin D analogs, Vitamin D2, Cholesterol and Lanolin derivatives. These products are used in pharmaceuticals, cosmetics, (shrimp) feed, and industrial applications. Through our history of Dishman Netherlands, Philips, Roxane, Duphar, and Solvay Pharmaceuticals we have more than 70 years of experience in the development, production, sales and distribution of these products.
Activities
CARBOGEN AMCIS B.V.
+31 318 545 754
info_veenendaal@carbogen-amcis.com
By public transport
By car
By plane
Christian Eich | Chairman + General Legal Counsel |
Pascal Villemagne | Delegate + Chief Executive Officer (CEO) |
Stephan Fritschi, Ph.D. | Delegate |
Arpit Vyas | Member |
Harshil Dalal | Member |
Ashok Gandhi | Member |
Ariane Gschwind | Secretary (not being a member) |
Pascal Villemagne | Chief Executive Officer (CEO) |
Stephan Fritschi, Ph.D. | Executive Vice-President Business Units; Deputy CEO |
Alan Fischer, Ph.D. | Vice President Innovation & M&A |
Dieter Thüer | Vice President Human Resources |
Martin Schneider, Ph.D. | Vice president Quality & ESH |
Mike Weiss | Vice President Finance / CFO |
François Baduel | Vice President Sales & Marketing |
Mara Guzzetti, Ph.D. | General Manager - Switzerland |
Carl Baker | General Manager - United Kingdom |
Angie Stevens | General Manager - France |
Harry Wong | General Manager - China |
Gerard Faaij | General Manager - The Netherlands |
CARBOGEN AMCIS is a leading service provider, offering a portfolio of drug development and commercialization services to the pharmaceutical and biopharmaceutical industries at all stages of drug development. Our integrated services for Drug Substances (DS) and Drug Products (DP) provide innovative solutions to support timely and safe drug development.